You are not logged in!
Do you want to login? It's free!
Who do you implu? Create a Free Account!
Attachment 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 13, 2009
Ultratech, Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 0-22248 | 94-3169580 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
| 3050 Zanker Road, San Jose, California | 95134 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code (408) 321-8835
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On October 13, 2009, the Board of Directors of Ultratech, Inc. (the “Company”) appointed Bin-ming Benjamin Tsai to its Board of Directors (the “Board”). Dr. Tsai will serve on the Board’s Compensation Committee.
There are no relationships or related transactions between the Company and Dr. Tsai that would be required to be reported under Section 404(a) of Regulation S-K. In connection with his appointment to the Board, Dr. Tsai will be compensated in accordance with the Company’s compensation arrangements for its non-employee Board members. The Company entered into an indemnification agreement with Dr. Tsai, the terms of which are identical in all material respects to the form of indemnification agreement that the Company has previously entered into with each of its directors and the form of which was filed with the Securities and Exchange Commission as Exhibit 10.1 to the Form 8-K filed by the Company on January 30, 2009.
On October 15, 2009, the Company issued a press release announcing Mr. Tsai’s appointment to the Board. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
| Item 9.01 | Financial Statements and Exhibits. |
| (d) | Exhibits |
| 99.1 | Press release. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Date: October 15, 2009
| ULTRATECH, INC. | ||
| By: | /s/ BRUCE R. WRIGHT | |
| Bruce R. Wright | ||
| Senior Vice President, Finance and Chief Financial Officer (Duly Authorized Officer and Principal Financial and Accounting Officer | ||
Exhibit Index
| Exhibit |
Description | |
| 99.1 |
Press release. | |